Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2009-11-03
2011-11-29
Huff, Sheela J (Department: 1643)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S135100, C530S387300
Reexamination Certificate
active
08066995
ABSTRACT:
Anti-myostatin antibodies are identified that are characterized as having high affinity and may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful for increasing muscle mass, increasing bond density, or for the treatment of various disorders in mammalian and avian species, X17251.
REFERENCES:
patent: 5639638 (1997-06-01), Wozney et al.
patent: 5700911 (1997-12-01), Wozney et al.
patent: 5827733 (1998-10-01), Lee et al.
patent: 5914234 (1999-06-01), Lee et al.
patent: 6096506 (2000-08-01), Lee et al.
patent: 6340668 (2002-01-01), Celeste et al.
patent: 6368597 (2002-04-01), Strassmann et al.
patent: 6437111 (2002-08-01), Wozney et al.
patent: 6468535 (2002-10-01), Lee et al.
patent: 6500664 (2002-12-01), Lee et al.
patent: 6517835 (2003-02-01), Lee et al.
patent: 6656475 (2003-12-01), Lee et al.
patent: 6696260 (2004-02-01), Lee et al.
patent: 6858208 (2005-02-01), Lee et al.
patent: 7175997 (2007-02-01), Wozney et al.
patent: 7179884 (2007-02-01), Lee et al.
patent: 7261893 (2007-08-01), Veldman et al.
patent: 7320789 (2008-01-01), Aghajanian et al.
patent: 7371726 (2008-05-01), Junker et al.
patent: 7511012 (2009-03-01), Han et al.
patent: 7534432 (2009-05-01), Lee et al.
patent: 7585648 (2009-09-01), Junker et al.
patent: 2002/0150577 (2002-10-01), Lee et al.
patent: 2003/0138422 (2003-07-01), Aghajanian et al.
patent: 2004/0142382 (2004-07-01), Veldman et al.
patent: 2004/0181033 (2004-09-01), Han et al.
patent: 2005/0014733 (2005-01-01), Whittemore et al.
patent: 2005/0043232 (2005-02-01), Lee et al.
patent: 2005/0143306 (2005-06-01), Junker et al.
patent: 2006/0034831 (2006-02-01), Tobin
patent: 2006/0240487 (2006-10-01), Nowak et al.
patent: 2006/0263354 (2006-11-01), Chin et al.
patent: 2007/0087000 (2007-04-01), Walsh et al.
patent: 2007/0149458 (2007-06-01), Han et al.
patent: 2007/0178095 (2007-08-01), Smith et al.
patent: 2007/0190056 (2007-08-01), Kambadur et al.
patent: 2008/0051328 (2008-02-01), Sharma et al.
patent: 2008/0187543 (2008-08-01), Kambadur et al.
patent: 2008/0299126 (2008-12-01), Han et al.
patent: 2009/0017045 (2009-01-01), Lee et al.
patent: 2009/0017522 (2009-01-01), Lee et al.
patent: 2009/0131638 (2009-05-01), Davies et al.
patent: 2009/0136481 (2009-05-01), Kambadur et al.
patent: 2009/0215671 (2009-08-01), Calof et al.
patent: 2009/0220491 (2009-09-01), Han et al.
patent: 2009/0311282 (2009-12-01), Junker et al.
patent: 1333035 (2003-08-01), None
patent: 2333706 (1999-04-01), None
patent: 94/21681 (1994-09-01), None
patent: 94/26892 (1994-11-01), None
patent: 96/01845 (1996-01-01), None
patent: 9835019 (1998-08-01), None
patent: 99/06559 (1999-02-01), None
patent: 99/24058 (1999-05-01), None
patent: 99/40181 (1999-08-01), None
patent: 00/43781 (2000-07-01), None
patent: 02/09641 (2002-02-01), None
patent: 02/10214 (2002-02-01), None
patent: 03/027248 (2003-04-01), None
patent: 2004/037861 (2004-05-01), None
patent: 2004/058988 (2004-07-01), None
patent: 2004/108157 (2004-12-01), None
patent: 2005066204 (2005-07-01), None
patent: 2005/094446 (2005-10-01), None
patent: 2006020884 (2006-02-01), None
patent: 2006/116269 (2006-11-01), None
patent: 2007/024535 (2007-03-01), None
patent: 2007/044411 (2007-04-01), None
patent: 2007047112 (2007-04-01), None
patent: 2007067616 (2007-06-01), None
patent: 2008/030706 (2008-03-01), None
patent: 2008109167 (2008-09-01), None
Ashmore, et al., “Comparative Aspects of Muscle Fiber Types in Fetuses of the Normal and ‘Double-Muscled’ Cattle,” Growth 38:501-506 (1974).
Bogdanovich, et al., “Functional Improvement of Dystrophic Muscle by Myostatin Blockade,” Nature 420:418-421 (2002).
Bogdanovich, et al., “Therapeutics for Duchenne Muscular Dystrophy: Current Approaches and Future Directions,” J. Mol. Med. 82:102-115 (2004).
Gamer, et al., “Gdf11 is a Negative Regulator of Chondrogenesis and Myogenesis in the Developing Chick Limb,” Dev. Biol. 229:407-420 (2001).
Gamer, et al., “A Novel BMP Expressed in Developing Mouse Limb, Spinal Cord, and Tail Bud Is a Potent Mesoderm Inducer in Xenopus Embryos,” Dev. Biol. 208:222-232 (1999).
Gonzalez-Cadavid, et al., “Organization of the Human Myostatin Gene and Expression in Healthy Men and HIV-Infected Men With Muscle Wasting,” PNAS 95:14938-14943 (1998).
Gonzales-Cadavid, et al., “Role of Myostatin in Metabolism,” Curr. Opin. Clin. Nutr. Metab. Care 7:451-457 (2004).
Grobet, et al., “A Deletion in the Bovine Myostatin Gene Causes the Double-Muscled Phenotype in Cattle,” Nature Genet. 17:71-74 (1997).
Hamrick, et al., “Femoral Morphology and Cross-Sectional Geometry of Adult Myostatin-Deficient Mice,” Bone 27:343-349 (2000).
Hamrick, et al., “Bone Mineral Content and Density in the Humerus of Adult Myostatin-Deficient Mice,” Calcif. Tissue Int. 71(1):63-68 (2002).
Hill, et al., “The Myostatin Propeptide and the Follistatin-Related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum,” J. Biol. Chem. 277:40735-40741 (2002).
Hill, et al., “Regulation of Myostatin in Vivo by Growth and Differentiation Factor-Associated Serum Protein-1: A Novel Protein with Protease Inhibitor and Follistatin Domains,” Mol. Endocrinol. 17:1144-1154 (2003).
Hoodless, et al., “Mechanisms and Function of Signaling by the TGF beta Superfamily,” Current Topics in Microbiology and Immunology pp. 236-272 (1998).
Huet, et al., “Skeletal Muscle Cell Hypertrophy Induced by Inhibitors of Metalloproteases; Myostatin as a Potential Mediator,” Am. J. Physiol. Cell. Physiol. 281:C1624-C1634 (2001).
Jiang, et al., “Characterization and Identification of the Inhibitory Domain of GDF-8 Propeptide,” Biochem. Biophys. Res. Commun. 315:525-531 (2004).
Kambadur, et al., “Mutations in Myostatin (GDF8) in Double-Muscled Belgian Blue and Piedmontese Cattle,” Genome Res. 7:910-915 (1997).
Kim, et al., “Inhibition of Preadipocyte Differentiation by Myostatin Treatment in 3T3-L1 Cultures,” Biochem. Biophys. Res. Comm., 281:902-906 (2001).
Kingsley, D.M., “The TGF beta Superfamily: New Members, New Receptors, and New Genetic Tests of Function in Different Organisms,” Genes & Devel. 8:133-146 (1994).
Kirk, et al., “Myostatin Regulation During Skeletal Muscle Regeneration,” J. Cell. Physiol., 184:356-363 (2000).
Lang, et al., “Regulation of Myostatin by Glucocorticoids After Thermal Injury,” FASEB J. 15:1807-1809 (2001).
Lee, et al., “Regulation of Myostatin Activity and Muscle Growth,” PNAS 98:9306-9311 (2001).
Li, et al., “Elimination of Myostatin Does Not Combat Muscular Dystophy in dy Mice but Increases Postnatal Lethality,” AJP. 166 (2) 491-497, 2005.
Lin, et al., “Myostatin Knockout in Mice Increases Myogenesis and Decreases Adipogenesis,” Biochem. Biophys. Res. Comm., 291:701-706 (2002).
Massagué, J., “The Transforming Growth Factor—beta Family,” Ann. Rev. Cell Biol. 6:597-641 (1990).
McPherron, et al., “Double Muscling in Cattle Due to Mutations in the Myostatin Gene,” PNAS 94:12457-12461 (1997).
McPherron, et al., “Regulation of Skeletal Muscle Mass in Mice by a New TGF—beta Superfamily Member,” Nature 387:83-90 (1997).
McPherron, et al., “Suppression of Body Fat Accumulation in Myostatin-Deficient Mice,” J. Clin. Invest. 109:595-601 (2002).
Muscaritoli, et al., “Therapy of Muscle Wasting in Cancer: What Is the Future?” Curr. Opin. Clin. Nutr. Metab. Care, 7:459-466 (2004).
Nakashima, et al., “Expression of Growth/Differentiation Factor 11, A New Member of the BMP/TGF beta Superfamily During Mouse Embryogenesis,” Mech. Dev. 80:185-189 (1999).
Reardon, et al., “Myostatin, Insulin-Like Growth Factor-1, and Leukemia Inhibitory Factor mRNAs Are Upreg
Davies Julian
Jones Bryan Edward
Korytko Andrew Ihor
Mitchell Pamela Jean
O'Bryan (Nee Tobias) Linda
Cox Gregory A.
Eli Lilly and Company
Huff Sheela J
LandOfFree
Anti-myostatin antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-myostatin antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-myostatin antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4279346